Peptide Support for Immune Health

Educational content only. The following article is based on published scientific research and is provided for informational purposes. It does not constitute medical advice, diagnosis, or a treatment recommendation. Individual responses to any therapy vary. All peptide protocols at Irvine Health are available only after a licensed physician video consultation and a written prescription.

The immune system is regulated by a complex network of signaling molecules — cytokines, chemokines, growth factors, and peptide hormones — that coordinate responses to pathogens, tissue damage, and cellular stress. Peptide therapies aimed at immune modulation have attracted research interest because peptides can interact with specific receptors and signaling cascades involved in immune function, potentially with greater selectivity than broad-spectrum immunosuppressants or non-specific immune stimulants.

Peptides With Immune Research Evidence

Thymosin Alpha-1

As detailed in our Thymosin Alpha-1 article, Tα1 is the most extensively studied immune-modulating peptide with clinical approval outside the US and randomized controlled trial data in viral hepatitis and sepsis contexts.

LL-37 (Cathelicidin)

Antimicrobial Peptide Research — Wang et al.

LL-37 is the only human cathelicidin — a naturally occurring antimicrobial peptide produced by neutrophils, macrophages, and epithelial cells. Beyond direct antimicrobial activity, research has characterized LL-37 as an immunomodulatory molecule that activates dendritic cell maturation, promotes wound healing, and exhibits anti-biofilm properties. Deficiency in LL-37 production has been linked to increased susceptibility to certain infections.

VIP (Vasoactive Intestinal Peptide)

Neuropeptide Immune Signaling — Delgado et al., Nat Rev Immunol (2004)

VIP, a neuropeptide produced throughout the nervous system and immune cells, binds VPAC1 and VPAC2 receptors on T cells, macrophages, and dendritic cells. Research demonstrates potent anti-inflammatory activity — suppression of pro-inflammatory cytokines (TNF-α, IL-6, IL-12) and upregulation of anti-inflammatory mediators. Aviptadil, a synthetic VIP analogue, has been studied in ARDS and pulmonary hypertension clinical trials.

Selank

Immunomodulatory Effects — Semenova et al. (Russian research, multiple)

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide derived from tuftsin, an endogenous tetrapeptide with established immunostimulatory activity. Russian research has reported effects on IL-6, interferon, and enkephalin systems, suggesting dual anxiolytic and immunomodulatory properties. Clinical trial data from large independent Western studies remain limited.

The Immune Health Context

Immune support is not a single concept — the immune system requires balance, not simply stimulation. Autoimmune conditions arise from immune overactivity; immunodeficiency from underactivity. Peptide-based immune support must therefore be tailored to the individual's immune context. Comprehensive immune evaluation — including lymphocyte subsets, inflammatory markers, and infectious disease screening — forms the foundation of any immune-support protocol prescribed by a licensed physician.

References

Goldstein AL, et al. History of Thymosin Research. Ann N Y Acad Sci. 2012;1270:1-7.
Wang G. Human antimicrobial peptides and proteins. Pharmaceuticals. 2014;7(5):545-94.
Delgado M, et al. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Nat Rev Immunol. 2004;4(4):327-38.
Semenova TP, et al. Effect of selank on cytokine expression in brain regions of rats. Bull Exp Biol Med. 2009;148(5):726-8.